Summary:
This study is to collect information from patients with Ulcerative Colitis who are already on Humira (Adalimumab).
The study will assess the safety and effectiveness of Humira.
It does not involve taking any other medication
Qualified Participants Must:
• Be at least 18 yrs of age
•
Diagnosed with moderately to severely active Ulcerative Colitis
•
Be taking Humira